Cargando…
Selective serotonin reuptake inhibitors-associated apathy syndrome: A cross sectional study
Selective serotonin reuptake inhibitors (SSRIs), commonly used to treat depression, are associated with loss of motivation, anergy, and lack of curiosity often referred collectively as apathy. However, this association has not been systematically assessed using a specific rating scale for measuring...
Autores principales: | Padala, Prasad R., Padala, Kalpana P., Majagi, Anusha S., Garner, Kimberly K., Dennis, Richard A., Sullivan, Dennis H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437849/ https://www.ncbi.nlm.nih.gov/pubmed/32871995 http://dx.doi.org/10.1097/MD.0000000000021497 |
Ejemplares similares
-
Successful Treatment of Treatment-Resistant Schizophrenia in a 10-Year-Catatonic Patient by Augmentation of Selective Serotonin Reuptake Inhibitors: A Case Report
por: Chen, Mei-Jung, et al.
Publicado: (2015) -
Comparative risk of Selective Serotonin Reuptake Inhibitors (SSRIs)-induced nausea among Chinese senile depression patients: A network meta-analysis of randomized-controlled trials
por: Guo, Shengyu, et al.
Publicado: (2020) -
Apathy syndrome in a patient previously treated with selective serotonin reuptake inhibitors for depression
por: Kim, Hye-Geum, et al.
Publicado: (2019) -
Neuromodulation for Apathy in Alzheimer’s Disease: A Double-Blind, Randomized, Sham-Controlled Pilot Study
por: Padala, Prasad R., et al.
Publicado: (2020) -
Selective serotonin reuptake inhibitor use associates with apathy among depressed elderly: a case-control study
por: Wongpakaran, Nahathai, et al.
Publicado: (2007)